Ubiquitin-mediated regulation of sterol homeostasis.

Cholesterol E3 ubiquitin ligases ER associated degradation (ERAD) HMG-CoA reductase LDL-cholesterol import RNF145 SCAP SREBP2 Sterol-induced HMGCR degradation Ubiquitin-mediated cholesterol homeostasis gp78

Journal

Current opinion in cell biology
ISSN: 1879-0410
Titre abrégé: Curr Opin Cell Biol
Pays: England
ID NLM: 8913428

Informations de publication

Date de publication:
08 2020
Historique:
received: 11 01 2020
revised: 03 04 2020
accepted: 26 04 2020
pubmed: 25 6 2020
medline: 7 1 2021
entrez: 25 6 2020
Statut: ppublish

Résumé

Cholesterol is an essential component of mammalian membranes, and its homeostasis is strictly regulated, with imbalances causing atherosclerosis, Niemann Pick disease, and familial hypercholesterolemia. Cellular cholesterol supply is mediated by LDL-cholesterol import and de novo cholesterol biosynthesis, and both pathways are adjusted to cellular demand by the cholesterol-sensitive SREBP2 transcription factor. Cholesterol homeostasis is modulated by a wide variety of metabolic pathways and the ubiquitination machinery, in particular E3 ubiquitin ligases. In this article, we review recent progress in understanding the role of E3 ubiquitin ligases in the metabolic control of cellular sterol homeostasis.

Identifiants

pubmed: 32580085
pii: S0955-0674(20)30056-9
doi: 10.1016/j.ceb.2020.04.010
pii:
doi:

Substances chimiques

Sterols 0
Ubiquitin 0
Hydroxymethylglutaryl CoA Reductases EC 1.1.1.-
Ubiquitin-Protein Ligases EC 2.3.2.27

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-111

Subventions

Organisme : Wellcome Trust
ID : 084957/Z/08/Z0
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/R001405/1
Pays : United Kingdom

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest statement Nothing declared.

Auteurs

Dick J H van den Boomen (DJH)

Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.

Norbert Volkmar (N)

Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom.

Paul J Lehner (PJ)

Cambridge Institute of Therapeutic Immunology & Infectious Disease, University of Cambridge, Cambridge, United Kingdom. Electronic address: pjl30@cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH